The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Solutions (Colloids) Market Research Report 2025
Synopsis
The global market for Intravenous Solutions (Colloids) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions (Colloids), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions (Colloids).
The Intravenous Solutions (Colloids) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Solutions (Colloids) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions (Colloids) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospital and Clinics
Ambulatory
Home Care
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Solutions (Colloids) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Intravenous Solutions (Colloids) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions (Colloids), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions (Colloids).
The Intravenous Solutions (Colloids) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Solutions (Colloids) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions (Colloids) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospital and Clinics
Ambulatory
Home Care
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Solutions (Colloids) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravenous Solutions (Colloids) Market Overview
1.1 Product Definition
1.2 Intravenous Solutions (Colloids) by Type
1.2.1 Global Intravenous Solutions (Colloids) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) by Application
1.3.1 Global Intravenous Solutions (Colloids) Market Value by Application (2024 VS 2031)
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Solutions (Colloids) Revenue 2020-2031
1.4.2 Global Intravenous Solutions (Colloids) Sales 2020-2031
1.4.3 Global Intravenous Solutions (Colloids) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Solutions (Colloids) Market Competition by Manufacturers
2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Solutions (Colloids), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
2.7 Global Key Manufacturers of Intravenous Solutions (Colloids), Date of Enter into This Industry
2.8 Global Intravenous Solutions (Colloids) Market Competitive Situation and Trends
2.8.1 Global Intravenous Solutions (Colloids) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Solutions (Colloids) Players Market Share by Revenue
2.8.3 Global Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Solutions (Colloids) Market Scenario by Region
3.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Solutions (Colloids) Sales by Region: 2020-2031
3.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2020-2025
3.2.2 Global Intravenous Solutions (Colloids) Sales by Region: 2026-2031
3.3 Global Intravenous Solutions (Colloids) Revenue by Region: 2020-2031
3.3.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2020-2025
3.3.2 Global Intravenous Solutions (Colloids) Revenue by Region: 2026-2031
3.4 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.4.1 North America Intravenous Solutions (Colloids) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Solutions (Colloids) Sales by Country (2020-2031)
3.4.3 North America Intravenous Solutions (Colloids) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.5.1 Europe Intravenous Solutions (Colloids) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Solutions (Colloids) Sales by Country (2020-2031)
3.5.3 Europe Intravenous Solutions (Colloids) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Solutions (Colloids) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Solutions (Colloids) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Solutions (Colloids) Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Solutions (Colloids) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous Solutions (Colloids) Sales by Type (2020-2031)
4.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2020-2025)
4.1.2 Global Intravenous Solutions (Colloids) Sales by Type (2026-2031)
4.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Solutions (Colloids) Revenue by Type (2020-2031)
4.2.1 Global Intravenous Solutions (Colloids) Revenue by Type (2020-2025)
4.2.2 Global Intravenous Solutions (Colloids) Revenue by Type (2026-2031)
4.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Solutions (Colloids) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Solutions (Colloids) Sales by Application (2020-2031)
5.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2020-2025)
5.1.2 Global Intravenous Solutions (Colloids) Sales by Application (2026-2031)
5.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Solutions (Colloids) Revenue by Application (2020-2031)
5.2.1 Global Intravenous Solutions (Colloids) Revenue by Application (2020-2025)
5.2.2 Global Intravenous Solutions (Colloids) Revenue by Application (2026-2031)
5.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Solutions (Colloids) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ICU Medical Inc.
6.1.1 ICU Medical Inc. Company Information
6.1.2 ICU Medical Inc. Description and Business Overview
6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
6.1.5 ICU Medical Inc. Recent Developments/Updates
6.2 B. Braun Melsungen AG
6.2.1 B. Braun Melsungen AG Company Information
6.2.2 B. Braun Melsungen AG Description and Business Overview
6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
6.2.5 B. Braun Melsungen AG Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Company Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Amanta Healthcare
6.5.1 Amanta Healthcare Company Information
6.5.2 Amanta Healthcare Description and Business Overview
6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
6.5.5 Amanta Healthcare Recent Developments/Updates
6.6 Terumo Medical Corporation
6.6.1 Terumo Medical Corporation Company Information
6.6.2 Terumo Medical Corporation Description and Business Overview
6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
6.6.5 Terumo Medical Corporation Recent Developments/Updates
6.7 Grifols S.A.
6.7.1 Grifols S.A. Company Information
6.7.2 Grifols S.A. Description and Business Overview
6.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
6.7.5 Grifols S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Solutions (Colloids) Industry Chain Analysis
7.2 Intravenous Solutions (Colloids) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Solutions (Colloids) Production Mode & Process Analysis
7.4 Intravenous Solutions (Colloids) Sales and Marketing
7.4.1 Intravenous Solutions (Colloids) Sales Channels
7.4.2 Intravenous Solutions (Colloids) Distributors
7.5 Intravenous Solutions (Colloids) Customer Analysis
8 Intravenous Solutions (Colloids) Market Dynamics
8.1 Intravenous Solutions (Colloids) Industry Trends
8.2 Intravenous Solutions (Colloids) Market Drivers
8.3 Intravenous Solutions (Colloids) Market Challenges
8.4 Intravenous Solutions (Colloids) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intravenous Solutions (Colloids) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Intravenous Solutions (Colloids) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Intravenous Solutions (Colloids) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intravenous Solutions (Colloids) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Intravenous Solutions (Colloids) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Intravenous Solutions (Colloids), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Solutions (Colloids), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Solutions (Colloids) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Intravenous Solutions (Colloids) Sales by Region (2020-2025) & (K Units)
Table 18. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2020-2025)
Table 19. Global Intravenous Solutions (Colloids) Sales by Region (2026-2031) & (K Units)
Table 20. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2026-2031)
Table 21. Global Intravenous Solutions (Colloids) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2020-2025)
Table 23. Global Intravenous Solutions (Colloids) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2026-2031)
Table 25. North America Intravenous Solutions (Colloids) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 27. North America Intravenous Solutions (Colloids) Sales by Country (2026-2031) & (K Units)
Table 28. North America Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Intravenous Solutions (Colloids) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Intravenous Solutions (Colloids) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Intravenous Solutions (Colloids) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Intravenous Solutions (Colloids) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Intravenous Solutions (Colloids) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Intravenous Solutions (Colloids) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Intravenous Solutions (Colloids) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2020-2025)
Table 51. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2026-2031)
Table 52. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2020-2025)
Table 53. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2026-2031)
Table 54. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2020-2025)
Table 57. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2026-2031)
Table 58. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2020-2025)
Table 59. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2026-2031)
Table 60. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2020-2025)
Table 61. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2026-2031)
Table 62. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2020-2025)
Table 63. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2026-2031)
Table 64. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2020-2025)
Table 67. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2026-2031)
Table 68. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2020-2025)
Table 69. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2026-2031)
Table 70. ICU Medical Inc. Company Information
Table 71. ICU Medical Inc. Description and Business Overview
Table 72. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. ICU Medical Inc. Intravenous Solutions (Colloids) Product
Table 74. ICU Medical Inc. Recent Developments/Updates
Table 75. B. Braun Melsungen AG Company Information
Table 76. B. Braun Melsungen AG Description and Business Overview
Table 77. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product
Table 79. B. Braun Melsungen AG Recent Developments/Updates
Table 80. Fresenius Kabi AG Company Information
Table 81. Fresenius Kabi AG Description and Business Overview
Table 82. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Fresenius Kabi AG Intravenous Solutions (Colloids) Product
Table 84. Fresenius Kabi AG Recent Developments/Updates
Table 85. Baxter Company Information
Table 86. Baxter Description and Business Overview
Table 87. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Baxter Intravenous Solutions (Colloids) Product
Table 89. Baxter Recent Developments/Updates
Table 90. Amanta Healthcare Company Information
Table 91. Amanta Healthcare Description and Business Overview
Table 92. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Amanta Healthcare Intravenous Solutions (Colloids) Product
Table 94. Amanta Healthcare Recent Developments/Updates
Table 95. Terumo Medical Corporation Company Information
Table 96. Terumo Medical Corporation Description and Business Overview
Table 97. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Terumo Medical Corporation Intravenous Solutions (Colloids) Product
Table 99. Terumo Medical Corporation Recent Developments/Updates
Table 100. Grifols S.A. Company Information
Table 101. Grifols S.A. Description and Business Overview
Table 102. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Grifols S.A. Intravenous Solutions (Colloids) Product
Table 104. Grifols S.A. Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Intravenous Solutions (Colloids) Distributors List
Table 108. Intravenous Solutions (Colloids) Customers List
Table 109. Intravenous Solutions (Colloids) Market Trends
Table 110. Intravenous Solutions (Colloids) Market Drivers
Table 111. Intravenous Solutions (Colloids) Market Challenges
Table 112. Intravenous Solutions (Colloids) Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravenous Solutions (Colloids)
Figure 2. Global Intravenous Solutions (Colloids) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intravenous Solutions (Colloids) Market Share by Type: 2024 & 2031
Figure 4. Peripheral Parenteral Nutrition Product Picture
Figure 5. Total Parenteral Nutrition Product Picture
Figure 6. Global Intravenous Solutions (Colloids) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Intravenous Solutions (Colloids) Market Share by Application: 2024 & 2031
Figure 8. Hospital and Clinics
Figure 9. Ambulatory
Figure 10. Home Care
Figure 11. Global Intravenous Solutions (Colloids) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Intravenous Solutions (Colloids) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Intravenous Solutions (Colloids) Sales (2020-2031) & (K Units)
Figure 14. Global Intravenous Solutions (Colloids) Average Price (USD/Unit) & (2020-2031)
Figure 15. Intravenous Solutions (Colloids) Report Years Considered
Figure 16. Intravenous Solutions (Colloids) Sales Share by Manufacturers in 2024
Figure 17. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Intravenous Solutions (Colloids) Players: Market Share by Revenue in Intravenous Solutions (Colloids) in 2024
Figure 19. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2031)
Figure 22. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2031)
Figure 26. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region (2020-2031)
Figure 34. China Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Intravenous Solutions (Colloids) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Intravenous Solutions (Colloids) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Intravenous Solutions (Colloids) by Type (2020-2031)
Figure 56. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Intravenous Solutions (Colloids) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Intravenous Solutions (Colloids) by Application (2020-2031)
Figure 59. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2020-2031)
Figure 60. Intravenous Solutions (Colloids) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
